CD4/CD8 ratio shifted after T cell transplantation, CD8+ CTLA4-T cells were growing faster in vivo, higher CD8+ T cell percentage was associated with higher anti-tumor efficacy (Supplementary Figure 2C–D). This evidence concerns the gene CD4 and neoplasm.